A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma

Clinical trial NCT06321250 · RECRUITING

Trial details

NCT number: NCT06321250
Sponsor: Jemincare
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Metastatic

Start date: 2024-03-14
Primary completion: 2026-05-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.